Cell surface expression and function of the macromolecular C1 complex on the surface of human monocytes

Frontiers in Immunology

Volumn 3, Issue MAR, 2012, Pages

  Hosszu, Kinga K ^a   Valentino, Alisa ^a   Ji, Yan ^a   Matkovic, Mara ^a   Pednekar, Lina ^a   Rehage, Nina ^a   Tumma, Nithin ^a   Peerschke, Ellinor I B ^b   Ghebrehiwet, Berhane ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

C1 complex; Complement; Immunology; Monocytes; U937 cells

Indexed keywords

EID: 84870691836     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00038     Document Type: Article

References (53)

1. Amano, M. T., Ferriani, V. P., Florido, M. P., Reis, E. S., Delcolli, M. I., Azzolini, A. E., Assis-Pandochi, A. I., Sjoholm, A. G., Farah, C. S., Jensenius, J. C., and Isaac, L. (2008). Genetic analysis of comple-ment C1s deficiency associated with systemic lupus erythematosus high-lights alternative splicing of nor-mal C1s gene. Mol. Immunol. 45, 1693-1702.
2. Arvieux, J., Reboul, A., Bensa, J. C., and Colomb, M. G. (1984). Character-ization of the C1q receptor on a human macrophage cell line, U937. Biochem. J. 218, 547-555.
3. Bensa, J. C., Reboul, A., and Colomb, M. G. (1983). Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes. Biochem. J. 216, 385-392.
4. Bobak, D. A., Gaither, T. A., Frank, M. M., and Tenner, A. J. (1987). Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J. Immunol. 138, 1150-1156.
5. Brodsky-Doyle, B., Leonard, K. R., and Reid, K. B. (1976). Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited pro-teolysis by pepsin. Biochem. J. 159, 279-286.
6. Calcott, M. A., and Muller-Eberhard, H. J. (1972). C1q protein of human complement. Biochemistry 11, 3443-3450.
7. Castellano, G., Woltman, A. M., Nauta, A. J., Roos, A., Trouw, L. A., Seelen, M. A., Schena, F. P., Daha, M. R., and van Kooten, C. (2004). Maturation of dendritic cells abrogates C1q pro-duction in vivo and in vitro. Blood 103, 3813-3820.
8. Cortes-Hernandez, J., Fossati-Jimack, L., Petry, F., Loos, M., Izui, S., Wal-port,M. J.,Cook,H. T.,and Botto,M. (2004). Restoration of C1q levels by bone marrow transplantation atten-uates autoimmune disease associ-ated with C1q deficiency in mice. Eur. J. Immunol. 34, 3713-3722.
9. Devitt, A., Parker, K. G., Ogden, C. A., Oldreive, C., Clay, M. F., Melville, L. A., Bellamy, C. O., Lacy-Hulbert, A., Gangloff, S. C., Goyert, S. M., and Gregory, C. D. (2004). Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/-mice. J. Cell Biol. 167, 1161-1170.
10. Dillon, S. P., D'Souza, A., Kurien, B. T., and Scofield, R. H. (2009). Systemic lupus erythematosus and C1q: a quantitative ELISA for determining C1q levels in serum. Biotechnol. J. 4, 1210-1214.
11. Drouet, C., and Reboul, A. (1989). Biosynthesis of C1r and C1s sub-components. Behring Inst. Mitt. 80-88.
12. Fremeaux-Bacchi, V., Weiss, L., Demouchy, C., Blouin, J., and Kazatchkine, M. D. (1996). Autoan-tibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Lupus 5, 216-220.
13. Ghebrehiwet, B., Lim, B. L., Peerschke, E. I., Willis, A. C., and Reid, K. B. (1994). Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular"heads"of C1q. J. Exp. Med. 179, 1809-1821.
14. Ghebrehiwet, B., Lu, P. D., Zhang, W., Lim, B. L., Eggleton, P., Leigh, L. E., Reid, K. B., and Peerschke, E. I. (1996). Identification of functional domains on gC1Q-R, a cell surface protein that binds to the globular "heads" of C1Q, using monoclonal antibodies and synthetic peptides. Hybridoma 15, 333-342.
15. Ghebrehiwet, B., and Peerschke, E. I. (2004). Role of C1q and C1q recep-tors in the pathogenesis of sys-temic lupus erythematosus. Curr. Dir. Autoimmun. 7, 87-97.
16. Gulati,P.,Lemercier,C.,Guc,D.,Lappin, D., and Whaley, K. (1993). Regula-tion of the synthesis of C1 subcom-ponents and C1-inhibitor. Behring Inst. Mitt. 196-203.
17. He, S., and Lin, Y. L. (1998). In vitro stimulation of C1s proteolytic activ-ities by C1s-presenting autoanti-bodies from patients with systemic lupus erythematosus. J. Immunol. 160, 4641-4647.
18. Hogasen, A. K., Hestdal, K., Hogasen, K., and Abrahamsen, T. G. (1995). Transforming growth factor beta modulates C3 and factor B biosyn-thesis and complement receptor 3 expression in cultured human monocytes. J. Leukoc. Biol. 57, 287-296.
19. Hosszu, K. K., Santiago-Schwarz, F., Peerschke, E. I., and Ghebrehiwet, B. (2010). Evidence that a C1q/C1qR system regulates monocyte-derived dendritic cell differentiation at the interface of innate and acquired immunity. Innate Immun. 16, 115-127.
20. Hughes-Jones, N. C. (1977). Func-tional affinity constants of the reaction between 125I-labelled C1q and C1q binders and their use in the measurement of plasma C1q concentrations. Immunology 32, 191-198.
21. Hurst, N. P., Nuki, G., and Walling-ton, T. (1984). Evidence for intrin-sic cellular defects of "complement" receptor-mediated phagocytosis in patients with systemic lupus erythe-matosus (SLE). Clin. Exp. Immunol. 55, 303-312.
22. Kang,Y. S., Do,Y., Lee, H. K., Park, S. H., Cheong, C., Lynch, R. M., Loeffler, J. M., Steinman, R. M., and Park, C. G. (2006). A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 125, 47-58.
23. Kaul, M., and Loos, M. (1995). Collagen-like complement compo-nent C1q is a membrane pro-tein of human monocyte-derived macrophages that mediates endocy-tosis. J. Immunol. 155, 5795-5802.
24. Kaul, M., and Loos, M. (2001). Expres-sion of membrane C1q in human monocyte-derived macrophages is developmentally regulated and enhanced by interferon-gamma. FEBS Lett. 500, 91-98.
25. Kuis, W., de Graeff-Meeder, E. R., Rijk-ers, G. T., Stoop, J. W., and Zegers, B. J. (1988). Disorders in humoral defense: clinical aspects, diagno-sis and therapy. Tijdschr. Kinderge-neeskd. 56, 184-192.
26. Lappin, D. F., McPhaden, A. R., Yap, P. L., Carter, P. E., Birnie, G. D., Fothergill, J. E., and Whaley, K. (1989). Monocyte C1-inhibitor syn-thesis in patients with C1-inhibitor deficiency. Eur. J. Clin. Invest. 19, 45-52.
27. Laufer, J., Katz, Y., and Passwell, J. H. (2001). Extrahepatic synthesis of complement proteins in inflamma-tion. Mol. Immunol. 38, 221-229.
28. Lee, S. L., Wallace, S. L., Barone, R., Blum, L., and Chase, P. H. (1978). Familial deficiency of two subunits of the first component of comple-ment. C1r and C1s associated with a lupus erythematosus-like disease. Arthritis Rheum. 21, 958-967.
29. Leist-Welsh, P., and Bjornson, A. B. (1982). Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes. J. Immunol. 128, 2643-2651.
30. Lepow, I. H., Naff, G. B., Todd, E. W., Pensky, J., and Hinz, C. F. (1963). Chromatographic resolution of the first component of human comple-ment into three activities. J. Exp. Med. 117, 983-1008.
31. Lu, J., Le, Y., Kon, O. L., Chan, J., and Lee, S. H. (1996). Biosynthe-sis of human ficolin, an Escherichia coli-binding protein, by monocytes: comparison with the synthesis of two macrophage-specific proteins, C1q and the mannose receptor. Immunology 89, 289-294.
32. Lucas, M., Stuart, L. M., Zhang, A., Hodivala-Dilke, K., Febbraio, M., Silverstein, R., Savill, J., and Lacy-Hulbert, A. (2006). Requirements for apoptotic cell contact in regu-lation of macrophage responses. J. Immunol. 177, 4047-4054.
33. Malhotra, R. (1993). Collectin recep-tor (C1q receptor): structure and function. Behring Inst. Mitt. 254-261.
34. Moosig, F., Damm, F., Knorr-Spahr, A., Ritgen, M., Zeuner, R. A., Kneba, M., Ernst, M., and Schroder, J. O. (2006). Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythe-matosus. Clin. Exp. Immunol. 146, 409-416.
35. Muller-Eberhard, H. J., and Kunkel, H. G. (1961). Isolation of a ther-molabile serum protein which pre-cipitates gamma-globulin aggregates and participates in immune hemol-ysis. Proc. Soc. Exp. Biol. Med. 106, 291-295.
36. Pickering, M. C., Macor, P., Fish, J., Durigutto, P., Bossi, F., Petry, F., Botto, M., and Tedesco, F. (2008). Complement C1q and C8beta defi-ciency in an individual with recur-rent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness. Rheumatology (Oxford) 47, 1588-1589.
37. Prellner, K., Sjoholm, A. G., Harsten, G., Heldrup, J., Kalm, O., and Korn-falt, R. (1989). C1q and C1 subcom-ponent complexes in otitis-prone and non-otitis-prone children. A prospective study of children during their first years of life. Acta Paediatr. Scand. 78, 911-917.
38. Randazzo, B. P., Dattwyler, R. J., Kaplan, A. P., and Ghebrehiwet, B. (1985). Synthesis of C1 inhibitor (C1-INA) by a human monocyte-like cell line, U937. J. Immunol. 135, 1313-1319.
39. Reid, K. B. (1989). Chemistry and mol-ecular genetics of C1q. Behring Inst. Mitt. 84, 8-19.
40. Reid, K. B., Gagnon, J., and Frampton, J. (1982). Completion of the amino acid sequences of the A and B chains of subcomponent C1q of the first component of human complement. Biochem. J. 203, 559-569.
41. Reid, K. B., and Porter, R. R. (1976). Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem. J. 155, 19-23.
42. Schuller, E., and Helary, M. (1983). Determination in the nanogram range of C1q in serum and unconcentrated CSF by electro-immunodiffusion. J. Immunol. Methods 56, 159-165.
43. Schwaeble, W., Schafer, M. K., Petry, F., Fink, T., Knebel, D., Weihe, E., and Loos, M. (1995). Follicular dendritic cells, interdigitating cells, and cells of the monocyte-macrophage lineage are the C1q-producing sources in the spleen. Identification of specific cell types by in situ hybridization and immunohistochemical analysis. J. Immunol. 155, 4971-4978.
44. Sjoholm, A. G., Martensson, U., and Laurell, A. B. (1985). C1 dissocia-tion in serum: estimation of free C1q by electroimmunoassay. Acta Pathol. Microbiol. Immunol. Scand. C 93, 161-168.
45. Steinsson, K., McLean, R. H., Merrow, M., Rothfield, N. F., and Weinstein, A. (1983). Selective complete Clq deficiency associated with systemic lupus erythematosus. J. Rheumatol. 10, 590-594.
46. Stuart, L. M., Takahashi, K., Shi, L., Sav-Ill, J., and Ezekowitz, R. A. (2005). Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoim-mune phenotype. J. Immunol. 174, 3220-3226.
47. Tenner, A. J., and Volkin, D. B. (1986). Complement subcomponent C1q secreted by cultured human mono-cytes has subunit structure identical with that of serum C1q. Biochem. J. 233, 451-458.
48. Tuckwell, D. S., Reid, K. B., Barnes, M. J., and Humphries, M. J. (1996). The A-domain of integrin alpha 2 binds specifically to a range of collagens but is not a general receptor for the collagenous motif. Eur. J. Biochem. 241, 732-739.
49. Vassallo, G., Newton, R. W., Chieng, S. E., Haeney, M. R., Shabani, A., and Arkwright, P. D. (2007). Clinical variability and char-acteristic autoantibody profile in primary C1q complement deficiency. Rheumatology (Oxford) 46, 1612-1614.
50. Vegh, Z., Goyarts, E. C., Rozengarten, K., Mazumder, A., and Ghebrehiwet, B. (2003). Maturation-dependent expression of C1q-binding pro-teins on the cell surface of human monocyte-derived dendritic cells. Int. Immunopharmacol. 3, 345-357.
51. Walport, M. J. (2002). Complement and systemic lupus erythematosus. Arthritis Res. 4(Suppl. 3), S279-S293.
52. Walport, M. J., Davies, K. A., and Botto, M. (1998). C1q and systemic lupus erythematosus. Immunobiology 199, 265-285.
53. Weiss,V.,Fauser,C.,and Engel,J. (1986). Functional model of subcomponent C1 of human complement. J. Mol. Biol. 189, 573-581